Uploaded October 2026 | Updated November 2026, 15 hours ago
How do you design a new medicine in stroke prevention?
In this episode of Science Is Boss, Bayer CEO Bill Anderson sits down with Bayer scientist Stefan Heitmeier to explore this decades-long scientific journey.
From testing thousands of molecules to pursuing a novel target, Stefan shares what it takes to turn a scientific hypothesis into a potential medicine. The conversation offers a rare look at the persistence, teamwork, and innovation that drive drug discovery.
In this episode:
- Why stroke prevention remains a critical unmet medical need
- How scientists searched through thousands of molecules to find the right candidate
- What it takes to advance from idea to development
Innovation in healthcare is rarely a straight path. Stefan's story is a powerful reminder of the dedication behind the search for new treatment options for patients.
#HealthForAll #HungerForNone
How do you design a new medicine in stroke prevention?
In this episode of Science Is Boss, Bayer CEO Bill Anderson sits down with Bayer scientist Stefan Heitmeier to explore this decades-long scientific journey.
From testing thousands of molecules to pursuing a novel target, Stefan shares what it takes to turn a scientific hypothesis into a potential medicine. The conversation offers a rare look at the persistence, teamwork, and innovation that drive drug discovery.
In this episode:
- Why stroke prevention remains a critical unmet medical need
- How scientists searched through thousands of molecules to find the right candidate
- What it takes to advance from idea to development
Innovation in healthcare is rarely a straight path. Stefan's story is a powerful reminder of the dedication behind the search for new treatment options for patients.
#HealthForAll #HungerForNone










